Plamotamab [2138442-31-4]

TargetMol Chemicals

Plamotamab

9

2138442-31-4

Antibody

Research Use Only

Plamotamab

Plamotamab (XmAb-13676), a human bispecific antibody (bsAb) targeting CD3 and CD20, recruits cytotoxic T cells to eliminate CD20-expressing tumor cells. It demonstrates mild hematologic reaction (MR) and effectively induces tumor regression in vivo [1] [2].

3 years

-20°C

12352203